Global Pediatric Drugs and Vaccines Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Jun-2019
No. of pages: 124
Inquire Before Buying

Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.

The global Pediatric Drugs and Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pediatric Drugs and Vaccines market based on company, product type, end user and key regions.

This report studies the global market size of Pediatric Drugs and Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pediatric Drugs and Vaccines in these regions.

This research report categorizes the global Pediatric Drugs and Vaccines market by top players/brands, region, type and end user. This report also studies the global Pediatric Drugs and Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Merck & Co., Inc. (USA)

- Abbott Laboratories (USA)

- Amgen, Inc. (USA)

- Eli Lilly and Company (USA)

- F. Hoffmann-La Roche Ltd (Switzerland)

- Genentech, Inc. (USA)

- GlaxoSmithKline plc. (UK)

- Janssen Biologics B.V. (USA)

- Actelion Pharmaceuticals

- AstraZeneca Plc. (UK)

- Boehringer Ingelheim GmbH (Germany)

- Bristol-Myers Squibb Company (USA)

- Allergan, Inc. (USA)

- Novartis AG (Switzerland)

- Novo Nordisk A/S (Denmark)

- Pfizer, Inc. (USA)

- Sanofi S.A (France)

- Shionogi Inc. (USA)

- Shire Pharmaceuticals Group Plc. (UK)

Market size by Product

- Diphtheria

- Influenza

- Hepatitis

- Pneumococcal Diseases

- Meningococcal Diseases

- Mumps

- Others

Market size by End User

- Newborn

- Infant

- Child

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Pediatric Drugs and Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Pediatric Drugs and Vaccines market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Pediatric Drugs and Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Pediatric Drugs and Vaccines submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pediatric Drugs and Vaccines are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pediatric Drugs and Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Pediatric Drugs and Vaccines Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Pediatric Drugs and Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Product
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Mumps
1.4.8 Others
1.5 Market by End User
1.5.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by End User
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Drugs and Vaccines Market Size
2.1.1 Global Pediatric Drugs and Vaccines Revenue 2014-2025
2.1.2 Global Pediatric Drugs and Vaccines Sales 2014-2025
2.2 Pediatric Drugs and Vaccines Growth Rate by Regions
2.2.1 Global Pediatric Drugs and Vaccines Sales by Regions
2.2.2 Global Pediatric Drugs and Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pediatric Drugs and Vaccines Sales by Manufacturers
3.1.1 Pediatric Drugs and Vaccines Sales by Manufacturers
3.1.2 Pediatric Drugs and Vaccines Sales Market Share by Manufacturers
3.1.3 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Pediatric Drugs and Vaccines Revenue by Manufacturers
3.2.1 Pediatric Drugs and Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 Pediatric Drugs and Vaccines Price by Manufacturers
3.4 Pediatric Drugs and Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Drugs and Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pediatric Drugs and Vaccines Sales by Product
4.2 Global Pediatric Drugs and Vaccines Revenue by Product
4.3 Pediatric Drugs and Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pediatric Drugs and Vaccines Breakdown Data by End User
6 North America
6.1 North America Pediatric Drugs and Vaccines by Countries
6.1.1 North America Pediatric Drugs and Vaccines Sales by Countries
6.1.2 North America Pediatric Drugs and Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pediatric Drugs and Vaccines by Product
6.3 North America Pediatric Drugs and Vaccines by End User
7 Europe
7.1 Europe Pediatric Drugs and Vaccines by Countries
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Countries
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pediatric Drugs and Vaccines by Product
7.3 Europe Pediatric Drugs and Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Pediatric Drugs and Vaccines by Countries
8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Countries
8.1.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pediatric Drugs and Vaccines by Product
8.3 Asia Pacific Pediatric Drugs and Vaccines by End User
9 Central & South America
9.1 Central & South America Pediatric Drugs and Vaccines by Countries
9.1.1 Central & South America Pediatric Drugs and Vaccines Sales by Countries
9.1.2 Central & South America Pediatric Drugs and Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pediatric Drugs and Vaccines by Product
9.3 Central & South America Pediatric Drugs and Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Drugs and Vaccines by Countries
10.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Countries
10.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pediatric Drugs and Vaccines by Product
10.3 Middle East and Africa Pediatric Drugs and Vaccines by End User
11 Company Profiles
11.1 Merck & Co., Inc. (USA)
11.1.1 Merck & Co., Inc. (USA) Company Details
11.1.2 Company Business Overview
11.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
11.1.5 Merck & Co., Inc. (USA) Recent Development
11.2 Abbott Laboratories (USA)
11.2.1 Abbott Laboratories (USA) Company Details
11.2.2 Company Business Overview
11.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
11.2.5 Abbott Laboratories (USA) Recent Development
11.3 Amgen, Inc. (USA)
11.3.1 Amgen, Inc. (USA) Company Details
11.3.2 Company Business Overview
11.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
11.3.5 Amgen, Inc. (USA) Recent Development
11.4 Eli Lilly and Company (USA)
11.4.1 Eli Lilly and Company (USA) Company Details
11.4.2 Company Business Overview
11.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
11.4.5 Eli Lilly and Company (USA) Recent Development
11.5 F. Hoffmann-La Roche Ltd (Switzerland)
11.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Details
11.5.2 Company Business Overview
11.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
11.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
11.6 Genentech, Inc. (USA)
11.6.1 Genentech, Inc. (USA) Company Details
11.6.2 Company Business Overview
11.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
11.6.5 Genentech, Inc. (USA) Recent Development
11.7 GlaxoSmithKline plc. (UK)
11.7.1 GlaxoSmithKline plc. (UK) Company Details
11.7.2 Company Business Overview
11.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
11.7.5 GlaxoSmithKline plc. (UK) Recent Development
11.8 Janssen Biologics B.V. (USA)
11.8.1 Janssen Biologics B.V. (USA) Company Details
11.8.2 Company Business Overview
11.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
11.8.5 Janssen Biologics B.V. (USA) Recent Development
11.9 Actelion Pharmaceuticals
11.9.1 Actelion Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
11.9.5 Actelion Pharmaceuticals Recent Development
11.10 AstraZeneca Plc. (UK)
11.10.1 AstraZeneca Plc. (UK) Company Details
11.10.2 Company Business Overview
11.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
11.10.5 AstraZeneca Plc. (UK) Recent Development
11.11 Boehringer Ingelheim GmbH (Germany)
11.12 Bristol-Myers Squibb Company (USA)
11.13 Allergan, Inc. (USA)
11.14 Novartis AG (Switzerland)
11.15 Novo Nordisk A/S (Denmark)
11.16 Pfizer, Inc. (USA)
11.17 Sanofi S.A (France)
11.18 Shionogi Inc. (USA)
11.19 Shire Pharmaceuticals Group Plc. (UK)
12 Future Forecast
12.1 Pediatric Drugs and Vaccines Market Forecast by Regions
12.1.1 Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2019-2025
12.2 Pediatric Drugs and Vaccines Market Forecast by Product
12.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Product 2019-2025
12.3 Pediatric Drugs and Vaccines Market Forecast by End User
12.4 North America Pediatric Drugs and Vaccines Forecast
12.5 Europe Pediatric Drugs and Vaccines Forecast
12.6 Asia Pacific Pediatric Drugs and Vaccines Forecast
12.7 Central & South America Pediatric Drugs and Vaccines Forecast
12.8 Middle East and Africa Pediatric Drugs and Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Drugs and Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Pediatric Drugs and Vaccines Product Picture
Table Pediatric Drugs and Vaccines Market Segments
Table Key Manufacturers Pediatric Drugs and Vaccines Covered
Table Global Pediatric Drugs and Vaccines Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Product 2014-2025
Figure Diphtheria Product Picture
Table Major Manufacturers of Diphtheria
Figure Influenza Product Picture
Table Major Manufacturers of Influenza
Figure Hepatitis Product Picture
Table Major Manufacturers of Hepatitis
Figure Pneumococcal Diseases Product Picture
Table Major Manufacturers of Pneumococcal Diseases
Figure Meningococcal Diseases Product Picture
Table Major Manufacturers of Meningococcal Diseases
Figure Mumps Product Picture
Table Major Manufacturers of Mumps
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Pediatric Drugs and Vaccines Market Size Growth Rate by End User 2019-2025 (MT)
Figure Newborn
Figure Infant
Figure Child
Figure Pediatric Drugs and Vaccines Report Years Considered
Figure Global Pediatric Drugs and Vaccines Market Size 2014-2025 (Million US$)
Figure Global Pediatric Drugs and Vaccines Sales 2014-2025 (MT)
Table Global Pediatric Drugs and Vaccines Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Pediatric Drugs and Vaccines Sales by Regions 2014-2019 (MT)
Table Global Pediatric Drugs and Vaccines Sales Market Share by Regions 2014-2019
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global Pediatric Drugs and Vaccines Sales Market Share by Regions
Table Global Pediatric Drugs and Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Market Share by Regions 2014-2019
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global Pediatric Drugs and Vaccines Revenue Market Share by Regions
Table Global Pediatric Drugs and Vaccines Sales by Manufacturers (2014-2019) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global Pediatric Drugs and Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Pediatric Drugs and Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2014-2019)
Figure Pediatric Drugs and Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers Pediatric Drugs and Vaccines Price (2014-2019) (USD/Kg)
Table Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pediatric Drugs and Vaccines Product Type
Table Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pediatric Drugs and Vaccines Sales by Product (2014-2019) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Product (2014-2019)
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Product (2014-2019)
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Product in 2018
Table Global Pediatric Drugs and Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Share by Product (2014-2019)
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Product (2014-2019)
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Product in 2018
Table Pediatric Drugs and Vaccines Price by Product 2014-2019 (USD/Kg)
Table Global Pediatric Drugs and Vaccines Sales by End User (2014-2019) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by End User (2014-2019)
Figure Global Sales Pediatric Drugs and Vaccines Market Share by End User (2014-2019)
Figure Global Sales Pediatric Drugs and Vaccines Market Share by End User in 2018
Figure North America Pediatric Drugs and Vaccines Sales Growth Rate 2014-2019 (MT)
Figure North America Pediatric Drugs and Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America Pediatric Drugs and Vaccines Sales by Countries (2014-2019) (MT)
Table North America Pediatric Drugs and Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America Pediatric Drugs and Vaccines Sales Market Share by Countries
Table North America Pediatric Drugs and Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America Pediatric Drugs and Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure United States Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure United States Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (MT)
Figure Canada Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Canada Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Mexico Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America Pediatric Drugs and Vaccines Sales by Product (2014-2019) (MT)
Table North America Pediatric Drugs and Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America Pediatric Drugs and Vaccines Market Share by Product
Table North America Pediatric Drugs and Vaccines Sales by End User (2014-2019) (MT)
Table North America Pediatric Drugs and Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America Pediatric Drugs and Vaccines Market Share by End User
Figure Europe Pediatric Drugs and Vaccines Sales Growth Rate 2014-2019 (MT)
Figure Europe Pediatric Drugs and Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Pediatric Drugs and Vaccines Sales by Countries (2014-2019) (MT)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Europe Pediatric Drugs and Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe Pediatric Drugs and Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure Germany Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Germany Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure France Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure UK Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Italy Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Russia Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Pediatric Drugs and Vaccines Sales by Product (2014-2019) (MT)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe Pediatric Drugs and Vaccines Market Share by Product
Table Europe Pediatric Drugs and Vaccines Sales by End User (2014-2019) (MT)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe Pediatric Drugs and Vaccines Market Share by End User
Figure Asia Pacific Pediatric Drugs and Vaccines Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Pediatric Drugs and Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Pediatric Drugs and Vaccines Sales by Countries (2014-2019) (MT)
Table Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Asia Pacific Pediatric Drugs and Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure China Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure China Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Japan Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Korea Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure India Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Australia Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Philippines Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Thailand Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Singapore Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Pediatric Drugs and Vaccines Sales by Product (2014-2019) (MT)
Table Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Pediatric Drugs and Vaccines Market Share by Product
Table Asia Pacific Pediatric Drugs and Vaccines Sales by End User (2014-2019) (MT)
Table Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Pediatric Drugs and Vaccines Market Share by End User
Figure Central & South America Pediatric Drugs and Vaccines Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Pediatric Drugs and Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Pediatric Drugs and Vaccines Sales by Countries (2014-2019) (MT)
Table Central & South America Pediatric Drugs and Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Central & South America Pediatric Drugs and Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Pediatric Drugs and Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure Brazil Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Brazil Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Argentina Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Pediatric Drugs and Vaccines Sales by Product (2014-2019) (MT)
Table Central & South America Pediatric Drugs and Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Pediatric Drugs and Vaccines Market Share by Product
Table Central & South America Pediatric Drugs and Vaccines Sales by End User (2014-2019) (MT)
Table Central & South America Pediatric Drugs and Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Pediatric Drugs and Vaccines Market Share by End User
Figure Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Pediatric Drugs and Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Middle East and Africa Pediatric Drugs and Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure GCC Countries Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Turkey Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure Egypt Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Pediatric Drugs and Vaccines Sales Growth Rate (2014-2019) (MT)
Figure South Africa Pediatric Drugs and Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales by Product (2014-2019) (MT)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Pediatric Drugs and Vaccines Market Share by Product
Table Middle East and Africa Pediatric Drugs and Vaccines Sales by End User (2014-2019) (MT)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Pediatric Drugs and Vaccines Market Share by End User
Table Merck & Co., Inc. (USA) Company Details
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck & Co., Inc. (USA) Recent Development
Table Abbott Laboratories (USA) Company Details
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Abbott Laboratories (USA) Recent Development
Table Amgen, Inc. (USA) Company Details
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Amgen, Inc. (USA) Recent Development
Table Eli Lilly and Company (USA) Company Details
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly and Company (USA) Recent Development
Table F. Hoffmann-La Roche Ltd (Switzerland) Company Details
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
Table Genentech, Inc. (USA) Company Details
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Genentech, Inc. (USA) Recent Development
Table GlaxoSmithKline plc. (UK) Company Details
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxoSmithKline plc. (UK) Recent Development
Table Janssen Biologics B.V. (USA) Company Details
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Janssen Biologics B.V. (USA) Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Actelion Pharmaceuticals Recent Development
Table AstraZeneca Plc. (UK) Company Details
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table AstraZeneca Plc. (UK) Recent Development
Table Boehringer Ingelheim GmbH (Germany) Company Details
Table Bristol-Myers Squibb Company (USA) Company Details
Table Allergan, Inc. (USA) Company Details
Table Novartis AG (Switzerland) Company Details
Table Novo Nordisk A/S (Denmark) Company Details
Table Pfizer, Inc. (USA) Company Details
Table Sanofi S.A (France) Company Details
Table Shionogi Inc. (USA) Company Details
Table Shire Pharmaceuticals Group Plc. (UK) Company Details
Table Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2019-2025 (MT)
Table Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global Pediatric Drugs and Vaccines Sales Forecast by Product 2019-2025 (MT)
Table Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global Pediatric Drugs and Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global Pediatric Drugs and Vaccines Sales Forecast by End User 2019-2025 (MT)
Table Global Pediatric Drugs and Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Pediatric Drugs and Vaccines Value Chain
Table Pediatric Drugs and Vaccines Customers List
Table Pediatric Drugs and Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs